Skip to main contentSkip to footer
Wordcloud representing the Clinical Trials Unit
Brighton & Sussex Medical School

Current studies

LIGHTMind 2

Low-Intensity Guided Help Through Mindfulness: A randomised controlled trial comparing supported mindfulness-based cognitive therapy self-help to supported cognitive behaviour therapy self-help for adults experiencing depression

Trial acronym: LIGHTMind 2

Description

Depression has serious personal, family and economic consequences. It is estimated that depression will cost £12.15 billion to the economy each year in England by 2026. Improving Access to Psychological Therapies (IAPT) is the NHS talking therapies service in England for adults experiencing anxiety or depression. Approximately 1 million people are referred to IAPT every year, over half experiencing depression. Where symptoms of depression are mild/moderate people are typically offered Cognitive Behaviour Therapy (CBT) self-help supported by a psychological wellbeing practitioner (PWP). The problem is that over half of people (58%) who complete treatment for depression in IAPT remain depressed despite receiving the NICE-recommended treatment. As well, less than half (40%) patients complete this treatment. This study seeks to investigate an alternative to CBT self-help. Mindfulness-based self-help, which differs from CBT in focus, approach and practice, could be more effective with lower dropout. The aim of this study is to comparing these two forms of self-help (CBT and Mindfulness).

Study design: Multi-centre, superiority pragmatic randomised controlled trial, with blinded assessments.

Trial status: Closed

Chief Investigator: Dr Clara Strauss, Sussex Partnership NHS Foundation Trust.

Start date: September 2017

End date: October 2019

Recruitment target: 410

Summary of study results: n/a 

For further information contact:

E: a.arbon@nhs.net